November 14, 2022
Article
The updated results were shared at the 2022 International Kidney Cancer Symposium.
November 03, 2022
Article
Researchers hope to find synergistic effects with the combination of the ribosomal RNA synthesis inhibitor pidnarulex and the PARP inhibitor talazoparib.
August 05, 2022
Article
The costimulatory bispecific antibody REGN5678 may alleviate resistance to immune checkpoint inhibition historically observed in prostate tumors.
June 01, 2022
Article
“This is a new standard of care when managing metastatic bladder cancer patients,” says Joaquim Bellmunt, MD, PhD.